What do we know about Kawasaki disease and COVID-19?

被引：2
|
作者：
Alberto Hernandez Arias, Jeffrey James William [1 ,2 ]
Herrera de la Hoz, Rosa Elena [2 ]
Lequerica Segrera, Pedro Luis [3 ]
机构：
[1] ESE Hosp San Juan Dios, Unidad Urgencias, Rionegro, Colombia
[2] Univ Cartagena, Cartagena, Colombia
[3] Univ Cartagena, Dept Pediatria, Cartagena, Colombia
来源：
ANDES PEDIATRICA | 2021年 / 92卷 / 02期
关键词：
COVID-19; SARS-CoV-2; Kawasaki Disease; Multisystem Inflammatory Syndrome; Pediatric; OUTBREAK;
D O I：
10.32641/andespediatr.v92i2.2786
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
In addition to the existing concern generated during the current COVID-19 pandemic outbreak in the adult population, we see how this pathology affects the pediatric population in the same way. Several countries have declared health alerts for a new syndrome that occurs late in children exposed to COVID-19, called "multisystem inflammatory syndrome". These patients manifest symptoms similar to Kawasaki disease, but at rare ages, and it is considered as the cytokine storm manifestation in children. The objective of this review is to present the available information on COVID-19 and its relationship with Kawasaki's disease, as well as to explain the current hypothesis of this new syndrome, its physiopathology, clinical presentation, key differences with Kawasaki's disease, and its possible therapeutic interventions.
引用
收藏
页码：281 / 287
页数：7
相关论文
共 50 条
  • [21] Covid-19: What do we know about the late stage vaccine candidates?
    Mahase, Elisabeth
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 371 : m4576
  • [22] Covid-19: What do we know about the delta omicron recombinant variant?
    Mahase, Elisabeth
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 376 : o792
  • [23] What Do We Really Know About Pulmonary Thrombosis in COVID-19 Infection?
    Raptis, Constantine A.
    Hammer, Mark M.
    Henry, Travis S.
    Hope, Michael D.
    Schiebler, Mark L.
    van Beek, Edwin J. R.
    [J]. JOURNAL OF THORACIC IMAGING, 2020, 35 (06) : 341 - 343
  • [24] CARDIAC TROPONINS AND COVID-19: WHAT DO WE KNOW ABOUT HETEROPHILIC ANTIBODIES?
    Campana, Pasquale
    Forzano, Imma
    Pepe, Marco
    Basile, Christian
    Perillo, Errico Federico
    Ranieri, Alessandro
    Conte, Maddalena
    Parisi, Valentina
    Sibilio, Gerolamo
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [25] Resuscitation in COVID-19 patients: What do we know and what should we do?
    Yilmaz, Ezgi
    Arsava, Ethem Murat
    Topcuoglu, Mehmet Akif
    [J]. CARDIOLOGY JOURNAL, 2020, 27 (05) : 656 - 657
  • [26] Pandemic preparedness beyond COVID-19: what we know, what we do, and what we do not
    Pericas, Juan M.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (05) : 574 - 575
  • [27] COVID-19 and cancer: do we really know what we think we know?
    Andrew G. Robinson
    Bishal Gyawali
    Gerald Evans
    [J]. Nature Reviews Clinical Oncology, 2020, 17 : 386 - 388
  • [28] COVID-19 and cancer: do we really know what we think we know?
    Robinson, Andrew G.
    Gyawali, Bishal
    Evans, Gerald
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (07) : 386 - 388
  • [29] Covid-19: What do we know about XBB.1.5 and should we be worried?
    Mahase, Elisabeth
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2023, 380 : p153
  • [30] COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
    Dhawan, Rahul
    Gundry, Rebekah L.
    Brett-Major, David M.
    Mahr, Claudius
    Thiele, Geoffrey M.
    Lindsey, Merry L.
    Anderson, Daniel R.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2020, 144 : 12 - 14
12345